[JinkoSolar Updates SHANGHAI, November 14, 2011 - For the third quarter of 2011, the Company expects: · Total solar module shipments to be approximately 210 MW – 220 MW, which compares with the Company’s previous guidance of 230 MW – 250 MW; · Total revenues to be in approximately US$270 – US$280 million, which compares with the Company’s previous guidance]
[FORM 10-Q (Mark One) x September 30, 2011 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]
[CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) (NYSE Ticker: CO) th 48 1 Garden Road Central Hong Kong S.A.R. NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 19, 2011 (or any adjourned or postponed meeting thereof) To the Shareholders of China Cord Blood Corporation th NOTICE IS HEREBY GIVEN that the 2011 Annual]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC Payment of Filing Fee (Check the appropriate box): þ No fee required.]
[CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) (NYSE Ticker: CO) th 48 1 Garden Road Central Hong Kong S.A.R. NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 19, 2011 (or any adjourned or postponed meeting thereof) To the Shareholders of China Cord Blood Corporation th NOTICE IS HEREBY GIVEN that the 2011 Annual]
[ChinaNet Online Announces Preliminary Third Quarter Financial Results and Full Year 2011 Revenue Guidance; Company Provides Business Update Q3 Revenues and Adjusted Net income expected to be at least $6.2 million and $1.0 million, respectively BEIJING, Nov. 10, 2011 -- ChinaNet Online Holdings, Inc. ("ChinaNet") (Nasdaq: CNET), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline]
